Alzheimer's in Long-Term Care--Treatment for Agitation
Completed
National Institute on Aging (NIA)
N/A
2001-01-01
The purpose of this study is to see if a medication called prazosin is useful in the
treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other
types of dementia in late life.
Alzheimer's in Long-Term Care--Treatment for Agitation
Completed
University of Washington
N/A
2001-01-01
The purpose of this study is to see if a medication called prazosin is useful in the
treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other
types of dementia in late life.
Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study
Completed
University of British Columbia
N/A
2004-12-01
Sexuality is a high rehabilitative priority for persons following a spinal cord injury (SCI).
Sexual acts can lead to autonomic dysreflexia (AD), dangerous consequences such as a sudden
increase in blood pressure, severe headache, sweating above the level of the lesion and low
heart rate to name a few. Ejaculation in men can provoke these significant symptoms and
therefore men and women may refrain from a sexual life and biological parenthood. Adalat is
the most common antihypertensive used in fertility clinics to reduce the incidence of AD. It
dramatically reduces blood pressure and, therefore, results in side effects such as
dizziness, fatigue and weakness. The investigators hypothesize that Minipress® (prazosin
HCL), a blood pressure medication, which has a slower and less abrupt suppressive effect on
blood pressure, would be a safe, effective and more appropriate medication for use in the
outpatient sperm retrieval clinic and potentially for private use.
Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
Terminated
National Institute of Mental Health (NIMH)
N/A
2003-10-01
This study will evaluate the effectiveness of prazosin in treating post-traumatic stress
disorder caused by noncombat trauma in individuals taking selective serotonin reuptake
inhibitors.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
